Entera Bio Ltd. (ENTX) Form 8-K — Jul 16, 2026

$ENTXForm 8-KItems 5.02, 5.03, 5.07, 9.01Filed Jul 16, 2026, 4:07 PM ET0001178913-26-003510Original filing

Entera Bio Ltd. shareholders approved an amendment to the company’s Amended and Restated Articles of Association to increase the number of authorized ordinary shares from approximately 140 million to 350 million shares at the 2026 Annual Meeting held on July 14, 2026. This expansion of authorized share capital is intended to provide flexibility for future corporate actions and financings. Additionally, shareholders approved an amendment to the 2018 Equity Incentive Plan to increase the number of ordinary shares issuable thereunder by a one-time amount of 2.5 million shares.

Key figures

Vote For Auditor: 25469339
Authorized Shares Pre: 140010000
Authorized Shares Post: 350000000
Vote For Share Increase: 24517240
Equity Plan Shares Added: 2500000
Vote Abstain Share Increase: 154377
Vote Against Share Increase: 837101
Vote For Director Sean Ellis: 11614671
Vote For Director Geno Germano: 11888019
Vote For Director Steven Rubin: 11126188

Price after filing

1 day: -1.0%7 days: +6.5%30 days: +44.5%

Close on the filing date to close N calendar days later (from $2.00). Historical, not a forecast.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.